|Day Low/High||5.50 / 5.50|
|52 Wk Low/High||2.05 / 5.60|
The company's stock symbol will revert to IMCL on July 10.
Merck KGaA files for clearance with European Union and Swiss regulators.
ABX-EGF works on tumors, but the Street might find the efficacy rates disappointing.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.